BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Egalet 

Lejrvej 37-41

Værløse    DK-3500  Denmark
Phone: 45-44-47-80-80 Fax: 45-44-47-24-25


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Egalet Reports Positive Top-Line Results From Category 1 Abuse Deterrence Studies Demonstrating Egalet-001 Resists Physical And Chemical Manipulation 7/15/2014 7:27:30 AM
Egalet To Present At Upcoming Investor Conferences In June 5/22/2014 9:31:03 AM
Egalet Reports First Quarter 2014 Financial Results And Provides Business Update 5/13/2014 6:49:28 AM
Egalet To Host Conference Call And Webcast To Discuss First Quarter 2014 Financial Results On May 13, 2014 4/29/2014 9:30:58 AM
Egalet To Present At The 13th Annual Needham Healthcare Conference On April 9 4/2/2014 9:09:33 AM
Egalet Added To Russell 3000, Russell 2000 And Russell Global Indexes 4/1/2014 9:24:28 AM
Egalet Reports Positive Outcome Of First Phase Of Category 1 Abuse Deterrence Studies For Egalet-001 3/31/2014 9:44:36 AM
Egalet Reports Full Year 2013 Financial Results And Provides Business Update 3/26/2014 6:21:11 AM
Egalet Initiates Bioequivalence Studies For Abuse-Deterrent Morphine Egalet-001 3/25/2014 9:19:18 AM
Egalet To Host Conference Call And Webcast To Discuss Fourth Quarter And Full Year 2013 Financial Results On March 26, 2014 3/13/2014 6:38:34 AM
123